Alka-seltzer Heartburn Relief Extra Strength Tablet, Effervescent
NDC Package 0280-0079-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Alka-seltzer Heartburn Relief Extra Strength (anhydrous citric acid, sodium bicarbonate (heat-treated)) tablets is uses for the relief of heartburnacid indigestionsour stomachupset stomach associated with these symptoms. This formulation utilizes a tablet, effervescent delivery system. Marketed by Bayer Healthcare Llc, this product is identified by NDC 0280-0079 and is authorized under FDA application M001.

Identification & Billing

NDC Package Code
0280-0079-01
Package Description
12 PACKET in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 PACKET
Product Code
11-Digit Billing Format
00280007901
RxNorm Crosswalk
  • RxCUI: 2571087 - citric acid 1000 MG / sodium bicarbonate 1976 MG Effervescent Oral Tablet
  • RxCUI: 2571087 - citric acid 1000 MG / NaHCO3 1976 MG Effervescent Oral Tablet

Clinical Specifications

Proprietary Name
Alka-seltzer Heartburn Relief Extra Strength
Non-Proprietary Name
Anhydrous Citric Acid, Sodium Bicarbonate (heat-treated)
Substance Name
Citric Acid Monohydrate; Sodium Bicarbonate
Dosage Form
Tablet, Effervescent - A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Uses for the relief of heartburnacid indigestionsour stomachupset stomach associated with these symptoms

Regulatory & Marketing

Labeler Name
Bayer Healthcare Llc
Product Type
Human Otc Drug
FDA Application #
M001
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-21-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0280-0079). Click a package code to view its specific billing and regulatory data.

36 PACKET in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 PACKET
18 PACKET in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 PACKET

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0280-0079-01 identifies a specific commercial package of 12 packet in 1 carton / 2 tablet, effervescent in 1 packet of Alka-seltzer Heartburn Relief Extra Strength, a human over the counter drug labeled by Bayer Healthcare Llc. This tablet, effervescent is formulated for oral use and contains citric acid monohydrate; sodium bicarbonate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bayer Healthcare Llc on September 21, 2021. The current certification is valid through December 31, 2026.

How is this Bayer Healthcare Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00280007901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0280-0079-01
11-Digit CMS (5-4-2)
00280-0079-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.